|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Sec Filings Insider Trading - Achillion Pharmaceuticals Inc (ACHN)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |
Achillion Pharmaceuticals Inc: Insider Trading and Stock Options
Common stock purchase or sale:
| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2012-12-31- -2013-01-02 Sale |
2013-01-03 5:42 pm | ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (EVP and Chief Compliance Ofc.) | 115,133 | $8.101 | $932,707 | 3,125 (Direct) | View |
| 2012-09-27 Sale | 2012-09-28 4:25 pm |
ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (EVP and Chief Compliance Ofc.) | 7,005 | $10 | $70,050 | 3,125 (Direct) |
View |
| 2012-09-12 Sale | 2012-09-12 5:49 pm | ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (EVP and Chief Compliance Ofc.) | 11,250 | $8 | $90,000 | 3,125 (Direct) | View |
| 2012-06-15 Sale |
2012-06-19 4:45 pm |
ACHILLION PHARMACEUTICALS INC | ACHN | WRIGHT DAVID P (Director) | 10,000 | $6.427 | $64,271 | 0 (Direct) | View |
| 2012-06-11- -2012-06-12 Purchase | 2012-06-13 4:38 pm |
ACHILLION PHARMACEUTICALS INC | ACHN | Liotta Dennis (Director) | 20,000 | $6.194 | $123,890 | 65,000 (Direct) |
View |
| 2012-06-11 Sale |
2012-06-13 4:37 pm | ACHILLION PHARMACEUTICALS INC | ACHN | FRASHIER GARY E (Director) | 16,250 | $6.186 | $100,514 | 5,000 (Direct) |
View |
| 2012-05-31 Sale |
2012-06-04 3:45 pm | ACHILLION PHARMACEUTICALS INC | ACHN | Clarus Lifesciences II, L.P. Clarus Ventures II GP, L.P. Clarus Ventures II, LLC LIPTAK ROBERT Simon Nicholas HENNER DENNIS GALAKATOS NICHOLAS WHEELER KURT STEINMETZ MICHAEL (10% owner) | 1,316,956 | $7.493 | $9,868,215 | 10,942,471 (Indirect) |
View |
| 2012-03-16- -2012-03-19 Sale |
2012-03-19 4:34 pm | ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (SVP and Chief Compliance Ofc.) | 4,796 | $10.72 | $51,405 | 3,125 (Direct) | View |
| 2012-01-10 Sale |
2012-01-11 5:41 pm |
ACHILLION PHARMACEUTICALS INC | ACHN | Olek Elizabeth A (SVP and CMO) | 12,468 | $10.06 | $125,428 | 2,000 (Direct) | View |
Other transactions:
| Transaction & Date |
Reported Date | Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Ownership |
Filing |
| 2013-01-18 Other |
2013-01-18 12:47 pm |
ACHILLION PHARMACEUTICALS INC | ACHN | VITULLO NICOLE (Director 10% owner) | 1,066,462 | $0 | $0 | 159,896 (Indirect) |
View |
| 2013-01-18 Other |
2013-01-18 12:38 pm |
ACHILLION PHARMACEUTICALS INC | ACHN | TREU JESSE I (10% owner) | 1,066,462 | $0 | $0 | 159,896 (Indirect) |
View |
| 2013-01-18 Other | 2013-01-18 12:31 pm | ACHILLION PHARMACEUTICALS INC | ACHN | SCHOEMAKER KATHLEEN K (10% owner) | 1,066,462 | $0 | $0 | 159,896 (Indirect) |
View |
| 2013-01-18 Other |
2013-01-18 12:27 pm |
ACHILLION PHARMACEUTICALS INC | ACHN | Halak Brian K (10% owner) | 1,066,462 | $0 | $0 | 159,896 (Indirect) | View |
| 2013-01-18 Other | 2013-01-18 12:23 pm | ACHILLION PHARMACEUTICALS INC | ACHN | DOVEY BRIAN H (10% owner) | 1,066,462 | $0 | $0 | 159,896 (Indirect) |
View |
| 2013-01-18 Other |
2013-01-18 12:15 pm |
ACHILLION PHARMACEUTICALS INC | ACHN | Domain Partners VIII, L.P. (10% owner) | 1,000,000 | $0 | $0 | 5,772,968 (Direct) |
View |
| 2013-01-18 Other |
2013-01-18 12:10 pm | ACHILLION PHARMACEUTICALS INC | ACHN | BLAIR JAMES C (10% owner) | 1,066,462 | $0 | $0 | 159,896 (Indirect) | View |
| 2012-12-31- -2013-01-02 Exercise |
2013-01-03 5:42 pm | ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (EVP and Chief Compliance Ofc.) | 115,133 | $2.844 | $327,491 | 30,090 (Direct) | View |
| 2012-09-27 Exercise | 2012-09-28 4:25 pm | ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (EVP and Chief Compliance Ofc.) | 7,005 | $4.82 | $33,764 | 10,130 (Direct) | View |
| 2012-09-12 Exercise |
2012-09-12 5:49 pm | ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (EVP and Chief Compliance Ofc.) | 11,250 | $2.693 | $30,300 | 14,375 (Direct) | View |
| 2012-06-15 Exercise |
2012-06-19 4:45 pm | ACHILLION PHARMACEUTICALS INC | ACHN | WRIGHT DAVID P (Director) | 10,000 | $2.66 | $26,600 | 10,000 (Direct) |
View |
| 2012-06-11 Exercise | 2012-06-13 4:37 pm | ACHILLION PHARMACEUTICALS INC | ACHN | FRASHIER GARY E (Director) | 16,250 | $1.05 | $17,062 | 21,250 (Direct) | View |
| 2012-06-04 Other | 2012-06-06 4:25 pm |
ACHILLION PHARMACEUTICALS INC | ACHN | Simon Nicholas (Director) | 73,593 | $0 | $0 | 22,078 (Direct Indirect) |
View |
| 2012-06-04 Other | 2012-06-06 4:23 pm | ACHILLION PHARMACEUTICALS INC | ACHN | Clarus Lifesciences II, L.P. Clarus Ventures II GP, L.P. Clarus Ventures II, LLC LIPTAK ROBERT HENNER DENNIS GALAKATOS NICHOLAS WHEELER KURT STEINMETZ MICHAEL (10% owner) | 10,942,468 | $0 | $0 | 3 (Indirect) | View |
| 2012-05-31 Exercise |
2012-06-04 3:45 pm | ACHILLION PHARMACEUTICALS INC | ACHN | Clarus Lifesciences II, L.P. Clarus Ventures II GP, L.P. Clarus Ventures II, LLC LIPTAK ROBERT Simon Nicholas HENNER DENNIS GALAKATOS NICHOLAS WHEELER KURT STEINMETZ MICHAEL (10% owner) | 2,997,348 | $3.292 | $9,868,206 | 12,259,427 (Indirect) |
View |
| 2012-05-31 Other |
2012-06-04 3:11 pm | ACHILLION PHARMACEUTICALS INC | ACHN | DOVEY BRIAN H (10% owner) | 1,293,434 | $0 | $0 | 93,434 (Indirect) | View |
| 2012-05-31 Other | 2012-06-04 3:08 pm | ACHILLION PHARMACEUTICALS INC | ACHN | VITULLO NICOLE (Director 10% owner) | 1,293,434 | $0 | $0 | 93,434 (Indirect) |
View |
| 2012-05-31 Other | 2012-06-04 3:05 pm | ACHILLION PHARMACEUTICALS INC | ACHN | Halak Brian K (10% owner) | 1,293,434 | $0 | $0 | 93,434 (Indirect) | View |
| 2012-05-31 Other |
2012-06-04 3:01 pm | ACHILLION PHARMACEUTICALS INC | ACHN | SCHOEMAKER KATHLEEN K (10% owner) | 1,293,434 | $0 | $0 | 93,434 (Indirect) |
View |
| 2012-05-31 Other | 2012-06-04 2:58 pm |
ACHILLION PHARMACEUTICALS INC | ACHN | TREU JESSE I (10% owner) | 1,293,434 | $0 | $0 | 93,434 (Indirect) | View |
| 2012-05-31 Other | 2012-06-04 2:55 pm |
ACHILLION PHARMACEUTICALS INC | ACHN | BLAIR JAMES C (10% owner) | 1,293,434 | $0 | $0 | 93,434 (Indirect) | View |
| 2012-05-31 Other |
2012-06-04 2:51 pm |
ACHILLION PHARMACEUTICALS INC | ACHN | Domain Partners VIII, L.P. (10% owner) | 1,200,000 | $0 | $0 | 6,772,968 (Direct) | View |
| 2012-03-16- -2012-03-19 Exercise | 2012-03-19 4:34 pm | ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (SVP and Chief Compliance Ofc.) | 4,796 | $2.016 | $9,670 | 5,203 (Direct) | View |
| 2012-01-10 Exercise |
2012-01-11 5:41 pm |
ACHILLION PHARMACEUTICALS INC | ACHN | Olek Elizabeth A (SVP and CMO) | 12,468 | $3.28 | $40,895 | 14,468 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction & Date | Reported Date |
Exercisable Expiration | Company | Symbol | Insider Relationship | Shares Traded | Conversion Price |
Shares Ownership | Filing |
| 2012-12-31 Exercise | 2013-01-03 5:42 pm |
N/A 2018-12-15 | ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (EVP and Chief Compliance Ofc.) | 14,899 | $1.05 | 0 (Direct) |
View |
| 2012-12-31 Exercise |
2013-01-03 5:42 pm |
N/A 2020-12-16 |
ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (EVP and Chief Compliance Ofc.) | 73,269 | $3.1 | 114,731 (Direct) | View |
| 2013-01-02 Exercise | 2013-01-03 5:42 pm | N/A 2019-12-18 | ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (EVP and Chief Compliance Ofc.) | 6,234 | $3.28 | 8,313 (Direct) |
View |
| 2013-01-02 Exercise |
2013-01-03 5:42 pm | N/A 2020-12-16 | ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (EVP and Chief Compliance Ofc.) | 20,731 | $3.1 | 94,000 (Direct) |
View |
| 2012-12-18 Option Award | 2012-12-20 6:26 pm | N/A 2022-12-18 | ACHILLION PHARMACEUTICALS INC | ACHN | WRIGHT DAVID P (Director) | 20,000 | $8.64 | 20,000 (Direct) | View |
| 2012-12-18 Option Award | 2012-12-20 6:26 pm | N/A 2022-12-18 | ACHILLION PHARMACEUTICALS INC | ACHN | Liotta Dennis (Director) | 20,000 | $8.64 | 20,000 (Direct) | View |
| 2012-12-18 Option Award | 2012-12-20 6:26 pm |
N/A 2022-12-18 |
ACHILLION PHARMACEUTICALS INC | ACHN | VAN NOSTRAND ROBERT L (Director) | 20,000 | $8.64 | 20,000 (Direct) |
View |
| 2012-12-18 Option Award |
2012-12-20 6:25 pm |
N/A 2022-12-18 | ACHILLION PHARMACEUTICALS INC | ACHN | Graves Kurt (Director) | 20,000 | $8.64 | 20,000 (Direct) |
View |
| 2012-12-18 Option Award |
2012-12-20 6:25 pm | N/A 2022-12-18 | ACHILLION PHARMACEUTICALS INC | ACHN | FISHERMAN JASON S (Director) | 20,000 | $8.64 | 20,000 (Direct) | View |
| 2012-12-18 Option Award |
2012-12-20 6:25 pm | N/A 2022-12-18 |
ACHILLION PHARMACEUTICALS INC | ACHN | FRASHIER GARY E (Director) | 20,000 | $8.64 | 20,000 (Direct) | View |
| 2012-12-18 Option Award |
2012-12-20 6:25 pm | N/A 2022-12-18 | ACHILLION PHARMACEUTICALS INC | ACHN | Scheer David (Director) | 20,000 | $8.64 | 20,000 (Direct) | View |
| 2012-12-18 Option Award | 2012-12-20 6:24 pm |
N/A 2022-12-18 |
ACHILLION PHARMACEUTICALS INC | ACHN | Truitt Joseph (SVP, Chief Commercial Officer) | 145,000 | $8.64 | 145,000 (Direct) | View |
| 2012-12-18 Option Award |
2012-12-20 6:24 pm | N/A 2022-12-18 | ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (EVP and Chief Compliance Ofc.) | 145,000 | $8.64 | 145,000 (Direct) | View |
| 2012-12-18 Option Award | 2012-12-20 6:23 pm |
N/A 2022-12-18 | ACHILLION PHARMACEUTICALS INC | ACHN | Fenton Mary Kay (SVP and CFO) | 145,000 | $8.64 | 145,000 (Direct) |
View |
| 2012-12-18 Option Award |
2012-12-20 6:23 pm |
N/A 2022-12-18 | ACHILLION PHARMACEUTICALS INC | ACHN | Deshpande Milind (President of R&D and CSO) | 145,000 | $8.64 | 145,000 (Direct) | View |
| 2012-12-18 Option Award | 2012-12-20 6:23 pm |
N/A 2022-12-18 |
ACHILLION PHARMACEUTICALS INC | ACHN | KISHBAUCH MICHAEL D (CEO and President Director) | 350,000 | $8.64 | 350,000 (Direct) |
View |
| 2012-12-18 Option Award | 2012-12-20 11:59 am | N/A 2022-12-18 | ACHILLION PHARMACEUTICALS INC | ACHN | VITULLO NICOLE (Director 10% owner) | 20,000 | $8.64 | 20,000 (Direct) |
View |
| 2012-09-27 Exercise |
2012-09-28 4:25 pm |
N/A 2012-09-27 |
ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (EVP and Chief Compliance Ofc.) | 7,005 | $4.82 | 0 (Direct) |
View |
| 2012-09-12 Exercise |
2012-09-12 5:49 pm |
N/A 2012-09-12 |
ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (EVP and Chief Compliance Ofc.) | 3,875 | $1.6 | 0 (Direct) | View |
| 2012-09-12 Exercise | 2012-09-12 5:49 pm | N/A 2012-09-12 |
ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (EVP and Chief Compliance Ofc.) | 2,250 | $1.6 | 0 (Direct) |
View |
| 2012-09-12 Exercise | 2012-09-12 5:49 pm |
N/A 2012-09-12 |
ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (EVP and Chief Compliance Ofc.) | 5,125 | $4 | 0 (Direct) |
View |
| 2012-09-04 Option Award |
2012-09-05 4:05 pm | N/A 2022-09-04 | ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (SVP and Chief Compliance Ofc.) | 30,000 | $7.1 | 30,000 (Direct) |
View |
| 2012-06-15 Exercise | 2012-06-19 4:45 pm |
2008-08-18 2008-08-18 |
ACHILLION PHARMACEUTICALS INC | ACHN | WRIGHT DAVID P (Director) | 10,000 | $2.66 | 0 (Direct) | View |
| 2012-06-11 Exercise | 2012-06-13 4:37 pm |
N/A 2018-12-15 |
ACHILLION PHARMACEUTICALS INC | ACHN | FRASHIER GARY E (Director) | 16,250 | $1.05 | 3,750 (Direct) | View |
| 2012-06-11 Option Award | 2012-06-13 4:37 pm | N/A 2022-06-11 | ACHILLION PHARMACEUTICALS INC | ACHN | Graves Kurt (Director) | 135,000 | $6.12 | 135,000 (Direct) |
View |
| 2012-05-31 Exercise | 2012-06-04 3:45 pm | 2010-08-20 2017-08-20 | ACHILLION PHARMACEUTICALS INC | ACHN | Clarus Lifesciences II, L.P. Clarus Ventures II GP, L.P. Clarus Ventures II, LLC LIPTAK ROBERT Simon Nicholas HENNER DENNIS GALAKATOS NICHOLAS WHEELER KURT STEINMETZ MICHAEL (10% owner) | 1,706,426 | $3.112 | 0 (Indirect) |
View |
| 2012-05-31 Exercise | 2012-06-04 3:45 pm |
2008-08-12 2015-08-12 |
ACHILLION PHARMACEUTICALS INC | ACHN | Clarus Lifesciences II, L.P. Clarus Ventures II GP, L.P. Clarus Ventures II, LLC LIPTAK ROBERT Simon Nicholas HENNER DENNIS GALAKATOS NICHOLAS WHEELER KURT STEINMETZ MICHAEL (10% owner) | 1,290,922 | $3.53 | 0 (Indirect) |
View |
| 2012-03-16 Exercise |
2012-03-19 4:34 pm | N/A 2018-12-15 | ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (SVP and Chief Compliance Ofc.) | 2,718 | $1.05 | 14,899 (Direct) | View |
| 2012-03-19 Exercise |
2012-03-19 4:34 pm |
N/A 2019-12-18 | ACHILLION PHARMACEUTICALS INC | ACHN | Shah Gautam (SVP and Chief Compliance Ofc.) | 2,078 | $3.28 | 14,547 (Direct) | View |
| 2012-01-10 Exercise | 2012-01-11 5:41 pm |
N/A 2019-12-18 |
ACHILLION PHARMACEUTICALS INC | ACHN | Olek Elizabeth A (SVP and CMO) | 12,468 | $3.28 | 20,782 (Direct) |
View |
|
© 2005-2013 SecForm4.Com All rights reserved. Archives: 2013 2012 2011 2010 2009 2008 ... Tue, 21 May 2013 15:25:44 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |